Early Clinically Important Improvement (ECII) and Exacerbation Outcomes in COPD Patients

BACKGROUND: Chronic obstructive pulmonary disease (COPD) exacerbations are difficult outcomes to measure in clinical trials. It would be valuable to be able to predict which patients are likely to benefit in terms of exacerbation prevention based on their early response in lung function and symptoms...

Descripción completa

Detalles Bibliográficos
Autores principales: Kostikas, Konstantinos, Mackay, Alexander J, Vogelmeier, Claus F, Frent, Stefan-Marian, Gupta, Pritam, Banerji, Donald, Patalano, Francesco, Pfister, Pascal J, Wedzicha, Jadwiga A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435751/
https://www.ncbi.nlm.nih.gov/pubmed/32884253
http://dx.doi.org/10.2147/COPD.S247966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435751/
https://www.ncbi.nlm.nih.gov/pubmed/32884253
http://dx.doi.org/10.2147/COPD.S247966

Ejemplares similares